Daily Note 25/04/2023 – Market View: Day Ahead, Macro, Stocks, Debt Markets


  • Another cautious session for risk assets yesterday with Europe, the UK and US markets relatively flat while the NASDAQ lagged behind with a decline.
  • Novartis has issued a strong set of Q123 numbers and upgraded full year guidance. Previous guidance of Group and Innovative Medicines (IM) revenue growth was in the low-to-mid single digit range. This has been tightened to mid-single digit range. (Comment attached)
  • A mixed session for core bond yields yesterday.